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m.2012.0Abstract Objective: The aim of this study is to determine the role of PROPELLER diffusion-
weighted MR imaging combined with conventional MR imaging for the detection of residual
cholesteatoma in patients who have undergone middle ear surgery.
Subjects and methods: Twenty patients who had undergone resection of cholesteatoma were referred
for MR imaging. MR imaging (1.5 T) was performed using a PROPELLER DWI, T2WI, FLAIR
and T1WI before and after IV injection of gadopentetate dimeglumine. An experienced reviewer
evaluated the diffusion-weighted MR images for the presence of a high-signal-intensity and calcu-
lated corresponding ADC values. Imaging ﬁndings were correlated with ﬁndings from surgery in 14
patients and with ﬁndings from clinical follow-up examination in six patients.
Results: Diffusion-weighted MR imaging combined with conventional MR imaging depicted eight
cholesteatomas. Two lesions were missed that were <3 mm. One patient was misdiagnosed as cho-
lesteatoma, biopsy revealed acute inﬂammation. Sensitivity was 80%, speciﬁcity was 90%, positive
predictive value was 89% and negative predictive value was 82%.
Conclusion: Diffusion-weighted MR imaging combined with conventional MRI and calculation of
ADC values is useful in the detection of secondary cholesteatoma and would decrease the need for
un-necessary second canal wall-up operation.
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544 D.M. Fahmy, S.M. Ragab1. Introduction
Unlike recurrent cholesteatoma, developing from recurring
retraction pockets or defects in the tympanic membrane recon-
struction, residual cholesteatoma cannot be detected by a simple
clinical examination [1]. Several methods, such as eustachian
tube endoscopy, have been proposed to detect residual choleste-
atomas [2]. However, these techniques are not routinely per-
formed and canal wall-up (CWU) tympanoplasties for middle
ear cholesteatoma usually require second-look surgery to rule
out the presence of residual cholesteatoma [1]. Identiﬁcation
of residual cholesteatoma and differentiation from postopera-
tive granulation tissue by non invasive technique to avoid sec-
ond look surgery are of great value.
Diffusion-weighted imaging is a technique that measures
the molecular diffusion of water (Brownian motion) within
the tissues [3]. Several reports have shown that diffusion-
weighted single-shot spin-echo echo-planar sequences can be
useful in the diagnosis of cholesteatomas [4–6]. The main prob-
lem facing DWI in this temporal bone region is susceptibility
artifacts. PROPELLER DWI is new technique developed to
overcome these artifacts.
The aim of this study is to determine the role of PROPEL-
LER diffusion-weighted MR imaging combined with conven-
tional MR imaging for the detection of residual cholesteatoma
in patients who have undergone middle ear surgery.
2. Patients and methods
This prospective study was performed after submission and
approval from the local ethics committee of our institution.
It was conducted at Taiba hospital (Kuwait) with the co-oper-
ation of radiology and ear, throat and larynx departments.
2.1. Patients
We evaluated 20 consecutive patients (7 female and 13 male
patients; mean age, 42 years; age range, 12–60 years) who
had undergone a canal wall-up mastoidectomy for a choleste-
atoma of the middle ear and underwent MR examination be-
fore surgery from August 2004 to March 2012. Surgery was
performed within 1–2 weeks after the MR examination and
18 months after the original operation.
2.2. Imaging technique
MR imaging was performed at 1.5 T (Optima 450w, GE,
Healthcare, Milwaukee, Wis) using a standard head coil with
eight elements (8 HR Brain; GE Healthcare).
The same protocol was used for all patients: axial fast SE T2-
weighted imaging (TR, 3203 ms; TE, 102 ms; ﬂip angle, 90;
bandwidth 41.7 kHz; matrix, 352 · 255, FOV 22 · 22, section
thickness 2 mm; intersection gap 0.2 mm, NEX 2, 20 sections,
duration 2 min 6 s), coronal fast SE T2-weighted imaging (TR,
3790 ms; TE, 102 ms; ﬂip angle, 90; bandwidth 35.7 kHz; ma-
trix, 352 · 255, FOV 19 · 19, section thickness 2 mm; intersec-
tion gap 0.2 mm, NEX 8, 15 sections, duration 2 min 47 s),
axial FLAIR imaging (TR 9000 ms; TE, 145 ms, TI 2200, band-
width 31.2 kHz; matrix, 352 · 255, FOV 24 · 24, section thick-
ness 1.5 mm; intersection gap 0.8 mm, NEX 1, 20 sections;
duration, 5 min 6 s), axial FSE T1-weighted imaging (TR240 ms; TE, 10.3 ms; bandwidth 25 kHz; matrix 320 · 256,
FOV 18 · 18, section thickness 2.5 mm; intersection gap,
0.5 mm,NEX3, 13 sections, duration 3 min 1 s), and axial PRO-
PELLER (multishot fast spin-echo periodically rotated overlap-
ping parallel lines with enhanced reconstruction) DWI (TR
5049 ms, TE 85.7 ms, EC 1/1, band width 83.3 kHz, FOV
24 · 24, section thickness 3 mm; intersection gap 0.2 mm,
NEX 1.5, 20 sections; duration: 4 min 23 s) were performed
using an echo train length of 24. Early axial FSE T1-weighted
postgadolinium (0.1 mmol/kg) and late axial FSE T1-weighted
postgadolinium (at least 45 min after contrast injection) with
the same parameters as axial FSE T1-weighted imaging.
Apparent diffusion coefﬁcient maps were used.
2.3. Imaging evaluation
The size of the lesion was measured in the greatest transverse
diameter on coronal T2-weighted SE images. High SI was con-
sidered in comparison to brain tissue. At least three ADC val-
ues were calculated for each lesion and the average value was
considered.
2.3.1. Granulation tissue without residual cholesteatoma was
diagnosed
Granulation tissue without residual cholesteatoma was diag-
nosed if the lesion had low signal intensity on unenhanced
T1-weighted images, had high signal intensity on T2-weighted
images, showed enhancement on delayed contrast-enhanced
T1-weighted images, and had low signal intensity on diffu-
sion-weighted images obtained with a b factor of 1000 s/mm2
(Fig. 1).
2.3.2. Residual cholesteatoma was diagnosed
Residual cholesteatoma was diagnosed if the lesion had low
signal intensity on unenhanced T1-weighted images, showed
no change in signal intensity on delayed contrast-enhanced
T1-weighted images, had high signal intensity on diffusion-
weighted images obtained with a b factor of 1000 s/mm2 in
comparison to brain tissue, with corresponding area of low
SI on ADC map (Fig. 2).
2.4. Histopathology
Histopathology was the gold standard in all patients who
underwent surgery after MR imaging. Because the surgical
technique was fractionated tissue resection, the tumor could
not be measured intra-operatively; therefore, lesion size was
determined using the MR images.
2.5. Statistical evaluation
The sensitivity, speciﬁcity, positive and negative predictive val-
ues of MR imaging in the diagnosis of cholesteatoma were
calculated.
Statistical analysis was done using SPPS for windows ver-
sion 13.
3. Results
Twenty cases were included. Two had lesions smaller than
5 mm and could not be evaluated well by MR diffusion. One
Fig. 1 (a) Axial T2 WI revealed high SI lesion within the meso-
tympanum. (b) Axial DWI; the lesion displays low SI in
comparison to brain tissue. Final diagnosis was granulation tissue
conﬁrmed by surgery.
Fig. 2 (a) Axial T2 WI revealed: A well deﬁned irregular lesion of ho
(b) Delayed post contrast T1 WI: the lesion shows thin marginal enh
comparison to the brain (white arrow). (d) ADC map: the lesion
granulation tissue.
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SI on DWI and no signiﬁcant enhancement on post contrast
study, but pathological analysis revealed acute inﬂammatory
process. The rest were nine granulation tissue and eight cases
of residual cholesteatoma. All eight cases of granulation tissue
showed low to faint SI on DWI, ADC ranged from 0.541 to
0.128 · 103 mm2/s (with a mean value of 0.33 ± 0.09),all
showed moderate enhancement on post contrast study. Apart
from the misdiagnosed case, all eight cases of residual choleste-
atoma showed high SI on DWI, ADC value ranged from 0.984
to 0. 563 · 103 mm2/s (with a mean value of 0.77 ± 0.13).
Three cases showed no signiﬁcant enhancement, while remain-
ing ﬁve showed marginal enhancement. No overlap was found
between ADC values of residual cholesteatoma and granula-
tion tissue with a cut off value of 0.55 · 103 mm2/s.
Sensitivity was 80%, speciﬁcity was 90%, positive predic-
tive value was 89% and negative predictive value was 82%.
(see Tables 1 and 2)4. Discussion
Acquired cholesteatomas generally occur in the middle ear and
mastoid, whereas congenital cholesteatomas or epidermoids
can occur in other locations, including the cerebellopontine an-
gle, suprasellar cistern, calvarium, and multiple sites in the
temporal bone. Congenital cholesteatomas compose only 2%
of middle ear cholesteatomas [7].
Acquired cholesteatoma consists of epithelial debris that
results from desquamation of the lining of the external audi-
tory canal and outer lining of the tympanic membrane. Themogenous high SI is seen in the right epitympanum. (white arrow).
ancement (white arrow). (c) DWI: the lesion displays high SI in
displays low SI (white arrow). . .ﬁnal diagnosis is postoperative
Table 1 overall results of detection of cholesteatoma using
DWI and delayed post contrast MRI.
Percentage
Sensitivity 80%
Speciﬁcity 90%
Positive predictive value 89%
Negative predictive value 82%
Table 2 ADC value · 10 in cases of residual cholesteatoma
and granulation tissue.
Cholesteatoma Granulation tissue
1 0.56 0.23
2 0.83 0.34
3 0.98 0.29
4 0.80 0.54
5 0.68 0.30
6 0.73 0.26
7 0.67 0.33
8 0.88 0.42
9 0.28
Mean ± SD 0.77 ± 0.13 0.33 ± 0.09
NB: One case was misdiagnosed as cholesteatoma, yet biopsy
revealed acute inﬂammation it displayed low ADC
value = 0.241 · 103 mm2/s).
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extirpation may be difﬁcult in advanced lesions. After surgery,
it is difﬁcult to distinguish between recurrent cholesteatoma
and granulation tissue from both clinical and radiologic stand-
points. The middle ear cavity is difﬁcult to visualize because of
postoperative scarring and thickening of the tympanic mem-
brane. The imaging appearance on both MR images and CT
scans is often nonspeciﬁc [8].
Patients with well-aerated postoperative mastoid bowls and
middle ear cavities can be easily evaluated with CT [6]. How-
ever, if a soft-tissue mass in the cavity of the middle ear is seen
on high-resolution CT, diagnosis of the mass is not possible
because cholesteatoma, mucoid secretion, granulation tissue,
ﬁbrous tissue, and cholesterol granuloma cannot be differenti-
ated from one another on high-resolution CT [9]. As a result,
many surgeons have to perform a follow-up procedure to
determine the cause of the mucosal thickening.
Diffusion weighted MRI (DWI) is a newly developed differ-
entiating tool between residual cholesteatoma and granulation
tissue. The differentiating point is that only cholesteatoma
shows high signal intensity on diffusion-weighted MR images.
Other tissues that can be found in the middle ear cavity after
surgery such as granulation tissue, ﬁbrous tissue, cholesterol
granuloma, or serous ﬂuid show low signal intensity on diffu-
sion-weighted MR images [10].
In this study we had correctly diagnosed 8 cases of residual
cholesteatoma which displayed high SI on DWI, 2 cases were
missed owing to their small size (<3 mm) and one case was
misdiagnosed as residual cholesteatoma but revealed acute
inﬂammation on surgical resection. Fitzek et al. [4] described
similar false positive case in their study which turned out to
be acute otitis media. We believe that acute inﬂammationdisplays high SI on DWI due to the presence of pus and high
protein content. On the other hand; that case showed very low
ADC value (0.241 · 103 mm2/s) which is lower than the mean
value calculated for other cholesteatoma lesions. We believe
that relying on both DWI and ADC values would have in-
creased the speciﬁcity of MR in detecting residual cholestea-
toma and decreased false positive cases.
Dremmen et al. [11] also described two false positive lesions
who showed high SI on DWI. Yet it was accompanied by
hyperintense signal intensity on T1-weighted images, consis-
tent with transplanted fat in the postoperative cavity. This
proves the value of combination of conventional MRI to
DWI.
On calculating ADC values, cholesteatoma did not show
low values when compared to granulation tissue. ADC values
ranged from 0.984 to 0. 563 · 103 mm2/s (with a mean value
of 0.77 ± 0.13 · 103 mm2/s). Granulation tissue displayed
lower values, as it ranged from 0.541 to 0.128 · 103 mm2/s
(with a mean value of 0.33 ± 0.09 · 103 mm2/s). This sup-
ports the hypothesis that a T2 shine through effect is predom-
inantly responsible for the hyperintensity on DWI not limited
diffusion. Similar results were reported by Vercruysse et al. [12]
who found that mean ADC values for cholesteatomas were
0.844 · 103 mm2/s).
We did not ﬁnd overlap between residual cholesteatoma
and granulation tissue on ADC values. A cut off value of
0.55 · 103 mm2/s could be used to differentiate between resid-
ual cholesteatoma and granulation tissue. Yet we still think
that small number of cases included in this study is not enough
to reach reliable statistical data regarding ADC values and lar-
ger study group would be needed.
Both echo-planar and non-echo-planar DWI techniques
have been utilized in detecting cholesteatoma. However, many
authors have favoured non-echo-planar DWI as it is less sus-
ceptible to the skull base distortion that can occur because
of the presence of an air–bone interface [12–16]. More recently,
another solution for this problem has been described that com-
bines echo-planar imaging with an image motion suppression
technique known as PROPELLER DWI [16].
In this study we used multishot fast spin-echo DWI-PRO-
PELLER technique. It showed sensitivity of 80%, speciﬁcity
of 90%, positive predictive value of 89% and negative predic-
tive value of 82%. It is considered the most recent method for
the diagnosis of residual cholesteatoma [17]. As previously
mentioned, the ability of DWI to be used consistently to eval-
uate the temporal bone is hindered by image distortion caused
by susceptibility artifacts, chemical-shift artifacts, and ghosts
in the phase-encoding direction. This is due to the high bone
attenuation of the inner ear and the numerous air-bone inter-
faces present within the mastoid air cells and the middle ear
cavity. With PROPELLER MR imaging, the marked reduc-
tion in off-resonance artifacts is primarily caused by the type
of sequence (fast SE): Fast SE imaging is less sensitive to
changes in the constant magnetic induction ﬁeld, because of
multiple 180 refocusing pulses. Reduction of susceptibility
artifacts is particularly important for adequate visualization
of the middle ear [13].
The main idea of PROPELLER DWI is radial k-space ﬁll-
ing technique, so MR imaging datasets are acquired in multi-
ple overlapping radial sections, each of which includes data
sampled from the center to the periphery of k-space [16].
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results from the fact that the periphery of k-space is more spar-
sely ﬁlled than its central region. It is difﬁcult with radial sam-
pling techniques to achieve the high spatial resolution
commonly expected in clinical practice because of the in-
creased acquisition time and decreased SNR [18]. Also it can
be performed only with axial sections, which does not optimize
visualization of the tegmen region [19].
Another drawback is increased scanning time when com-
pared to DWI-EPI. This makes it more liable to the motion
artifacts. But fortunately, because the evaluation of cholestea-
toma requires only limited coverage, the resulting 4 min 23 s
scanning time was tolerated well by patients included in this
study.
As previously mentioned; cholesteatoma is composed of an
enlarging collection of exfoliated keratin within a sac of strat-
iﬁed squamous epithelium that shows no change in signal
intensity on contrast-enhanced MR images [20]. Conversely,
granulation tissue shows enhancement only on delayed con-
trast-enhanced images owing to its ﬁbrous nature and, possi-
bly, to the microvascular thrombosis phenomenon [21]. It is
necessary to obtain delayed contrast-enhanced images with a
delay of 30–45 min after contrast material administration.
Ayache et al. [22] achieved high diagnostic results with this
technique as they have correctly detected 17 out of 19 residual
cholesteatoma with overall sensitivity of 90%; speciﬁcity of
100%; positive predictive value of 100%; negative predictive
value of 92%. They missed two lesions which were <3 mm.
These results are slightly higher than ours.
The main disadvantage to this technique is long duration.
In the usual practice patients would not accept to wait for
45 min.
De Foer et al. [23] showed that the concurrent use of non-
echo planar HASTE DWI and delayed contrast-enhanced MR
yielded no signiﬁcant increase in diagnostic performance over
the use of non-echo planar DWI alone. In the current study
we found similar ﬁndings as regard both the false positive
and false negative cases. Delayed post contrast MRI did not
diagnose lesions <3 mm. Also the case with acute inﬂamma-
tion showed marginal enhancement which was misleading.
We believe that the addition of ADC map to DWI will be more
helpful than delayed post contrast.
Limitations to this included small number of cases. Suscep-
tibility artifacts made it difﬁcult to have clear images. Also we
could not evaluate lesions less than 3 mm. Thus, additional
studies including lesions smaller than 3 mm are needed to de-
ﬁne the role of the diffusion-weighted sequence in the detection
of small recurrent cholesteatoma.
5. Conclusion
DWI with ADC map is useful in the detection of secondary
cholesteatoma and would decrease the need for un-necessary
second canal up operation.
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